236 related articles for article (PubMed ID: 30651043)
1. Evolving the Role of Discovery-focused Pathologists and Comparative Scientists in the Pharmaceutical Industry.
Mohanan S; Maguire S; Klapwijk J; Adler R; Haworth R; Clements P
Toxicol Pathol; 2019 Feb; 47(2):121-128. PubMed ID: 30651043
[TBL] [Abstract][Full Text] [Related]
2. The role of the toxicologic pathologist in the biopharmaceutical industry.
van Tongeren S; Fagerland JA; Conner MW; Diegel K; Donnelly K; Grubor B; Lopez-Martinez A; Bolliger AP; Sharma A; Tannehill-Gregg S; Turner PV; Wancket LM
Int J Toxicol; 2011 Oct; 30(5):568-82. PubMed ID: 21878555
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Forum Opinion Piece*: Veterinary Pathologists in Translational Pharmacology and Biomarker Integration in Drug Discovery and Development.
Ramaiah SK; Walker DB
Toxicol Pathol; 2016 Feb; 44(2):137-46. PubMed ID: 26839329
[TBL] [Abstract][Full Text] [Related]
4. Veterinary clinical pathologists in the biopharmaceutical industry.
Schultze AE; Bounous DI; Bolliger AP
Vet Clin Pathol; 2008 Jun; 37(2):146-58. PubMed ID: 18533913
[TBL] [Abstract][Full Text] [Related]
5. Toxicologic pathology in a multicultural world--India.
Schultze AE; Reddy VR; Donnelly KB; Berridge BR
Toxicol Pathol; 2011 Oct; 39(6):1003-9. PubMed ID: 21859882
[TBL] [Abstract][Full Text] [Related]
6. Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective.
Wong H; Bohnert T; Damian-Iordache V; Gibson C; Hsu CP; Krishnatry AS; Liederer BM; Lin J; Lu Q; Mettetal JT; Mudra DR; Nijsen MJMA; Schroeder P; Schuck E; Suryawanshi S; Trapa P; Tsai A; Wang H; Wu F
Drug Discov Today; 2017 Oct; 22(10):1447-1459. PubMed ID: 28476536
[TBL] [Abstract][Full Text] [Related]
7. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective.
Ewart L; Fabre K; Chakilam A; Dragan Y; Duignan DB; Eswaraka J; Gan J; Guzzie-Peck P; Otieno M; Jeong CG; Keller DA; de Morais SM; Phillips JA; Proctor W; Sura R; Van Vleet T; Watson D; Will Y; Tagle D; Berridge B
Exp Biol Med (Maywood); 2017 Oct; 242(16):1579-1585. PubMed ID: 28622731
[TBL] [Abstract][Full Text] [Related]
8. Challenges and Opportunities for the Veterinary Pathologist in Biomedical Research.
Hoenerhoff MJ; Meyerholz DK; Brayton C; Beck AP
Vet Pathol; 2021 Mar; 58(2):258-265. PubMed ID: 33327888
[TBL] [Abstract][Full Text] [Related]
9. Screening a novel class of anticoagulants for multi-organ toxicity using Fischer 344 rats: involvement of clinical and anatomic pathologists in the early drug development process.
Schultze AE; Sullivan JM
Vet Clin Pathol; 2007 Jun; 36(2):123-36. PubMed ID: 17523085
[TBL] [Abstract][Full Text] [Related]
10. Current practices in preclinical drug development: gaps in hemostasis testing to assess risk of thromboembolic injury.
Schultze AE; Walker DB; Turk JR; Tarrant JM; Brooks MB; Pettit SD
Toxicol Pathol; 2013; 41(3):445-53. PubMed ID: 22991386
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery: new models for industry-academic partnerships.
Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
[TBL] [Abstract][Full Text] [Related]
12. Regulatory Forum Opinion Piece
Morgan SJ; Couch J; Guzzie-Peck P; Keller DA; Kemper R; Otieno MA; Schulingkamp RJ; Jones TW
Toxicol Pathol; 2017 Apr; 45(3):372-380. PubMed ID: 28351296
[TBL] [Abstract][Full Text] [Related]
13. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
Campbell JB
IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
[TBL] [Abstract][Full Text] [Related]
14. Computational chemistry at Janssen.
van Vlijmen H; Desjarlais RL; Mirzadegan T
J Comput Aided Mol Des; 2017 Mar; 31(3):267-273. PubMed ID: 27995515
[TBL] [Abstract][Full Text] [Related]
15. Conference report: a hitchhiker's guide to outsourcing ADME studies: the inside of outsourcing.
Pritchard JF; Anderson SR; Breuckner C; Premkumar ND; Polli JW
Bioanalysis; 2013 Feb; 5(4):403-5. PubMed ID: 23414372
[TBL] [Abstract][Full Text] [Related]
16. Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
Vanderwall DE; Yuen N; Al-Ansari M; Bailey J; Fram D; Green DV; Pickett S; Vitulli G; Luengo JI; Almenoff JS
Drug Discov Today; 2011 Aug; 16(15-16):646-53. PubMed ID: 21601652
[TBL] [Abstract][Full Text] [Related]
17. Essential Contributions of Pathologists and Laboratory Physicians Leading to the Discovery of Insulin.
Wright JR
Arch Pathol Lab Med; 2020 Jul; 144(7):894-904. PubMed ID: 31825669
[TBL] [Abstract][Full Text] [Related]
18. Accessing external innovation in drug discovery and development.
Tufféry P
Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
[TBL] [Abstract][Full Text] [Related]
19. Strategies for conducting ADME studies during lead generation in the drug discovery process.
Cramer JW; Mattioni BE; Savin KA
IDrugs; 2010 Dec; 13(12):857-61. PubMed ID: 21154143
[TBL] [Abstract][Full Text] [Related]
20. Effective integration of systems biology, biomarkers, biosimulation and modelling in streamlining drug development.
Krishna R; Schaefer HG; Bjerrum OJ
Eur J Pharm Sci; 2007 May; 31(1):62-7. PubMed ID: 17408933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
